Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Laryngeal cancer and airway compromise

Oncology and palliative care · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Impending upper-airway obstruction

Inspiratory stridor, increasing work of breathing, inability to lie flat or handle secretions, hypoxaemia, exhaustion, cyanosis or altered consciousness indicates a critically narrowed laryngeal airway.

Action: Call senior anaesthesia and ENT immediately, keep the patient upright and calm with high-concentration oxygen and suction, avoid unplanned sedation or paralysis, move to the best controlled location and agree awake endoscopic intubation, tracheostomy and front-of-neck rescue options before instrumentation; do not send an unstable patient to CT.

Synopsis

Recognise glottic, supraglottic and subglottic cancer, distinguish stable hoarseness from impending obstruction, investigate safely and choose treatment that balances cure with voice, swallowing and airway function.

  • Glottic cancer classically causes persistent progressive hoarseness early; supraglottic cancer more often causes sore throat, dysphagia, odynophagia, referred otalgia, aspiration or a neck node.
  • First-line diagnostic assessment is flexible nasendoscopy by a trained clinician, but a severely compromised patient needs a controlled airway plan before repeated examination or transfer.
  • The diagnostic reference standard is direct laryngoscopy with biopsy and histology once the airway is secure; do not biopsy a precarious obstructing lesion in an uncontrolled setting.
  • Contrast CT neck and chest stages cartilage, spaces, nodes, airway and thoracic disease; MRI adds selected cartilage, soft-tissue, tongue-base or prevertebral detail.
  • Early glottic disease is commonly treated with one modality, such as transoral laser microsurgery or radiotherapy, with broadly high local control and different voice trade-offs.
  • Locally advanced disease may need total laryngectomy with neck and risk-adapted adjuvant therapy or organ-preserving chemoradiotherapy after realistic functional assessment.
  • Dexamethasone and nebulised adrenaline may temporarily reduce oedema in selected acute cases, but neither removes tumour and neither should delay definitive airway control.
  • Avoid sedatives, opioids and neuromuscular blockade before a shared difficult-airway plan when spontaneous ventilation is maintaining a critically narrow airway.
  • A tracheostomy may retain an upper-airway connection; a total-laryngectomy stoma does not. In laryngectomy, apply oxygen and ventilate through the stoma only.
  • Smoking cessation, nutrition, dental preparation, swallowing therapy, voice rehabilitation and emergency stoma education are integral to treatment.

Key red flags

Stridor at rest, drooling, severe recession, silent airflow, fatigue, cyanosis or reduced consciousness requires an immediate controlled airway response.

Progressive or persistent unexplained hoarseness, especially with tobacco exposure, warrants urgent laryngeal visualisation rather than repeated reflux treatment.

Odynophagia, dysphagia, referred otalgia, haemoptysis, weight loss, neck mass or aspiration suggests invasive or supraglottic disease.

A patient after total laryngectomy breathes only through the neck stoma; oral or nasal oxygen and intubation cannot ventilate the lungs.

Fresh tracheostomy or stoma bleeding, especially a pulsatile sentinel bleed, can precede major vessel haemorrhage and needs immediate surgical and major-haemorrhage support.

Threatened airway

Stridor at rest, inability to speak normally, secretion intolerance, recession, orthopnoea, cyanosis or exhaustion requires immediate airway action.

Laryngectomy anatomy

A mature end stoma without upper-airway airflow, loss of normal voice and a neck-breather alert identifies total laryngectomy rather than simple tracheostomy.

Investigation priorities

01
First-line flexible nasendoscopyFirst stepFirst line

Visualise supraglottis, glottis, subglottic inlet, pooling, tumour and vocal-cord movement and assess airway calibre.

02
First-line contrast CT neck and chest for stagingFirst line

Assess laryngeal spaces, cartilage, extralaryngeal spread, cervical nodes, airway, lung metastasis and synchronous lung cancer.

Management branches

Critical airwaySecure oxygenation without losing spontaneous ventilation

The patient has rest stridor, severe work of breathing, secretion intolerance, hypoxaemia or exhaustion.

  1. Call senior ENT, anaesthesia and critical care, keep upright and calm, give oxygen, attach monitoring and prepare suction and difficult-airway equipment while identifying prior tracheostomy or laryngectomy anatomy.
  2. Agree the planned and rescue airway before drugs or transfer; a controlled awake approach, rigid endoscopic debulking, tracheostomy or front-of-neck access may be selected according to level and anatomy.
  3. Treat oedema or infection concurrently when suspected, but regard steroid, adrenaline or antibiotics as bridges and proceed to definitive airway control if clinical obstruction persists or progresses.
Stable suspected cancerVisualise, image and biopsy

Persistent hoarseness or another suspicious laryngeal symptom is present without immediate compromise.

  1. Arrange urgent specialist head-and-neck examination and flexible nasendoscopy, documenting cord mobility, neck nodes, swallowing and airway symptoms.
  2. Obtain contrast CT neck and chest and selected MRI, then perform direct laryngoscopy and biopsy in a setting matched to anticipated airway difficulty.

Key medicines

Dexamethasone as an airway bridgeFor significant tumour-associated upper-airway oedema, a specialist may give dexamethasone 8 mg intravenously initially and continue 4 to 8 mg every 6 to 12 hours for the shortest effective period while definitive airway treatment proceeds; follow the local airway protocol.Do not delay airway control for response. Monitor glucose, delirium, infection and gastrointestinal risk, document duration and taper after more prolonged use; infection or haemorrhage may need different concurrent treatment.
Nebulised adrenaline as a temporary bridgeIn a monitored resuscitation area, use the locally approved nebulised adrenaline regimen for acute upper-airway oedema only after senior airway review; repeat dosing and concentration must follow that protocol.Effect may wear off and tumour bulk remains. Monitor heart rate, rhythm and blood pressure and never send the patient away or to unmonitored imaging because stridor briefly improves.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG36 head and neck cancerLaryngeal assessment, staging, treatment, function and rehabilitation.
  • NICE NG12 suspected cancer referralPersistent hoarseness and neck-lump referral criteria.
  • National Tracheostomy Safety Project emergency careAdult emergency algorithms distinguishing tracheostomy from laryngectomy and oxygenation routes.
  • BNF dexamethasoneSystemic corticosteroid adverse effects, cautions and monitoring.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Complete pathological and nodal stage and baseline dental, nutritional, voice, swallow, pulmonary, renal and hearing assessment before the MDT treatment decision.